(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

INIBIDORES DE MET QUINASE

ArquivadaInvention PatentPCT · US2022081504

Application data

Number

112024012133

Type

Invention Patent

Filing

12/14/2022

Publication

09/17/2024

PCT

US2022081504

Progress at the INPI

  1. Filing12/14/22
  2. Publication09/17/24
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 12/14/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/17/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

KINNATE BIOPHARMA INC.

US

See this company's full portfolio

Inventors

J. C. (pessoa física)

US

J. T. (pessoa física)

US

R. K. (pessoa física)

US

T. K. (pessoa física)

US

X. O. (pessoa física)

US

Technical data

Priority claims

US

63/290,291 · 12/16/2021

US

63/301,267 · 01/20/2022

US

63/380,049 · 10/18/2022

US

63/386,647 · 12/08/2022

Abstract

INIBIDORES DE MET QUINASE. São fornecidos aqui inibidores de MET receptor tirosina quinase, composições farmacêuticas que compreendem os referidos compostos inibidores, e métodos para utilização dos referidos compostos inibidores de MET quinase para o tratamento de doença.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

03/17/2026

RPI 2880

Arquivamento - Art. 33 da LPI

#11.1

12/23/2025

RPI 2868

Notificação de entrada na fase nacional - PCT

#1.3

09/17/2024

RPI 2802

Alteração de dados cadastrais

#1.1

06/25/2024

RPI 2790

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.